$AMIX 8-K SEC Filings

Filed On	Filing
16 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation Appointment adds more than four decades of MedTech leadership, FDA regulatory and strategic transaction experience, including work supporting renal denervation and other category-defining technologies
26 Aug 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
28 Jul 2026	8-K: Other Events
15 Jul 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
10 Jul 2026	8-K: Other Events
24 Jun 2026	8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
16 Jan 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
09 Jan 2026	8-K: Regulation FD Disclosure
19 Nov 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
03 Nov 2025	8-K: Submission of Matters to a Vote of Security Holders
27 Aug 2025	8-K: Other Events
26 Aug 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
22 Jul 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
30 Apr 2025	8-K: Regulation FD Disclosure
28 Feb 2025	8-K: Entry into a Material Definitive Agreement; Other Events
13 Feb 2025	8-K: Results of Operations and Financial Condition
22 Jan 2025	8-K: Regulation FD Disclosure
25 Nov 2024	8-K: Entry into a Material Definitive Agreement; Other Events
12 Nov 2024	8-K: Results of Operations and Financial Condition
04 Nov 2024	8-K: Other Events

Comments